TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: HIV-1 RNA levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CD4 cell counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Allodynia Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: SANS total score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SANS avolition subscale score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ≥20% reduction in SANS avolition score
Endpoint domain: Adverse events/effects
Primary endpoint: RBV concentration at week 8
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: postoperative pain level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: patient satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: time for comfortable crutch ambulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hemoglobin A1c (HbA1c) values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Body mass index (BMI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incidence of any rectal bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of moderate/severe rectal bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: flexural eczema on skin examination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Antitumor responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Moderate/severe toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: Partial Response Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of reported adverse drug reactions (ADRs)
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of serious adverse drug reactions (ADRs)
Endpoint domain: Adverse events/effects
Primary endpoint: Successful treatment rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Incidence of food aversions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Wound dehiscence rate
Endpoint domain: Adverse events/effects
Primary endpoint: freedom from death, surgery, or 3+ or 4+ MR
Endpoint domain: Mortality/survival
Primary endpoint: anxiety
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 12-month TLR rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: death
Endpoint domain: Mortality/survival
Primary endpoint: mean BWAT score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pain VAS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: wound-QoL global score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Bruise or hematoma occurrence
Endpoint domain: Adverse events/effects
Primary endpoint: Pain VAS scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: modified Rankin Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fat mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Serum triglyceride concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: interobserver contouring variability in overall prostate volumes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 4 year mortality
Endpoint domain: Mortality/survival
Primary endpoint: death or spontaneous myocardial infarction (MI) until 3 years
Endpoint domain: Mortality/survival
Primary endpoint: Complete response rates by day 10
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Normalization of CSC by day 4
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median duration of complete response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Three-year recurrence-free survival
Endpoint domain: Mortality/survival
Primary endpoint: Five-year overall survival
Endpoint domain: Mortality/survival
Primary endpoint: Bath AS Patient Global Score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Work Productivity and Activity Index (WPAI) presenteeism
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: MOS Short Form‐36 (SF‐36) physical component
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: LV ejection fraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: LV volumes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: LVSV response to exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: LVEDV increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: LVESV reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: AUCt
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Major adverse cardiovascular events (MACE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Completion of follow-up questionnaires
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: APT suppression of at least 1 ETFAD grade
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: clinical outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: radiographic outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: operative time
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: mean FLACC pain score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PPI prescriptions reduction
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Clinician consultations reduction
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Quality of life improvement (EuroQol-5D)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Partial ST-segment resolution at 12 h
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Re-infarction rates at 30 days
Endpoint domain: Adverse events/effects
Primary endpoint: Disabling stroke rate
Endpoint domain: Adverse events/effects
Primary endpoint: pain response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: adverse effects to treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Reengagement in outpatient HIV care
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Weight loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fear of negative evaluation (FNE)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Weight-related teasing (WRT)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: morning pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FFI-disability score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: pain threshold
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: perception
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in attitudes toward breast cancer
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Better relationships with significant others
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: macronutrient intakes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: number of different carbohydrate food choices per day
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: ankle mobility
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Progesterone levels in GC culture
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Androstenedione levels in GC culture
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Early luteinization prevention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: satisfaction with care
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: attendance at appointments
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Weight-for-age z score (WAZ)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Length-for-age z score (LAZ)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incremental area under the glucose curve (iAUC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: YMRS total scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FEV1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: AHR (Airway Hyperresponsiveness)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: mean improvement in International Index of Erectile Function erectile function domain score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Systolic Blood Pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Diastolic Blood Pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Viable cell count after treatments
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Metabolic syndrome odds ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Triglycerides
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Utilization of formal help
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Duration of mediastinal nodal dissection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Cumulative chest tube drainage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: all-cause death and hospitalization for prespecified cardiovascular causes
Endpoint domain: Mortality/survival
Primary endpoint: CGI‐21 Anxiety score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Confirmed CTEPH or PPEI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Reduction in neck and arm pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in health-related quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Rate of secondary surgical procedures
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Pain affecting daily activities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Participation in sporting activities
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Sick leave exceeding 1 week due to groin pain
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Search performance score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: small artery compliance (C2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Area under the plasma concentration-time curve (AUC(infinity))
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Observed maximum plasma concentrations (C(max))
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pharmacokinetic profiles of R- or S-warfarin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: live birth rate
Endpoint domain: Mortality/survival
Primary endpoint: successful pregnancies
Endpoint domain: Mortality/survival
Primary endpoint: Opacification Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of PCO
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Need for Nd:YAG capsulotomy
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Myoelectrical muscle fatigue
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Health-related quality of life (HR-QOL)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in HbA1c
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Body weight change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Diabetes treatment-related quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: NIHSS improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Mini‐Mental State Examination improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Montreal Cognitive Assessment improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Satisfaction with treatment
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Persistence of treatment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Compliance with treatment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Plasma omentin-1 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: incidence of postoperative complaints
Endpoint domain: Adverse events/effects
Primary endpoint: ESS score increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: systolic blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: diastolic blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: ODI scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adjusted mean reduction in the Liebowitz Social Anxiety Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Response rates for social anxiety symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Remission rates for social anxiety symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of invasive-ventilation-free-days at day 28
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Minimum alveolar concentration for satisfactory tracheal extubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: fracture risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Posttraumatic growth
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Rate of treatment success
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Achieving target blood pressures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: 2-Year Survival Rate (2-YSR)
Endpoint domain: Mortality/survival
Primary endpoint: Median Survival
Endpoint domain: Mortality/survival
Primary endpoint: R0 Resection Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: increase in antibody levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: mean knowledge score change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: intentions to clean hands
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: intentions to ask providers about MRSA status
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: dislocation rate
Endpoint domain: Adverse events/effects
Primary endpoint: Length of stay
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Average blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Symptomatic benefits
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Acceptability of bimonthly home specimen collection
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Feasibility of bimonthly home specimen collection
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Weight loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Feeding intolerance
Endpoint domain: Adverse events/effects
Primary endpoint: Trunk inclination at impact
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Trunk bending to the side of the impacted shoulder
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Trunk rotation to the side of the impacted shoulder
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Influenza virus infection rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Vaccine coverage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvements in memory
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Improvements in executive function
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Improvements in worry severity
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Percentage of participants achieving loss of 50% of excess weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean weight loss in kg
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Blood ammonia levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Hepatic function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PDMS-2 scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: anesthesia pain score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: suturing pain score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: onset time of total anesthesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean change in serum phosphorus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Reduction in posttraumatic stress symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in overall psychosocial distress
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in prosocial behaviour
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Cardiovascular responses to intubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Bronchodilator response (BDR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Quality of life measured by St. George's Respiratory Questionnaire total score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Rate of hospitalization
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Mortality rate
Endpoint domain: Mortality/survival
Primary endpoint: combined incidence of cardiac death, target‐vessel‐related myocardial infarction, or target‐lesion revascularization
Endpoint domain: Mortality/survival
Primary endpoint: Levels of secretory leukocyte protease inhibitor (SLPI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Development of hepatocellular carcinoma
Endpoint domain: Mortality/survival
Primary endpoint: Sustained aminotransferase normalisation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Low back pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neck pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum levels of SAA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Serum levels of adiponectin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Serum levels of leptin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Occurrence of extrapancreatic infection
Endpoint domain: Adverse events/effects
Primary endpoint: Need for surgery
Endpoint domain: Resource use
Primary endpoint: Length of hospitalization
Endpoint domain: Resource use
Primary endpoint: health status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: urinary symptoms and bother
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: prostate-related knowledge
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status